ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 368,500
-11,500 (-3.03%)
Apr 30, 2026, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 20.33 trillion as of April 30, 2026. Its market cap has increased by 5.11% in one year.
Market Cap
20.33T
Enterprise Value
20.01T
Revenue
215.86B
Ranking
n/a
PE Ratio
146.65
Stock Price
368,500.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 20.33T, an increase of 16,851.14%. That is a compound annual growth rate of 56.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 19.72T | -17.98% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.19T |
| Celltrion | 42.76T |
| Samsung Epis Holdings | 13.91T |
| Kolon TissueGene | 9.10T |
| HLB Co., Ltd. | 8.37T |
| SK Biopharmaceuticals | 7.97T |
| LigaChem Biosciences | 7.09T |
| Peptron | 6.30T |